Annual CFF
$87.00 M
-$32.70 M-27.32%
31 December 2023
Summary:
CG Oncology Common stock annual cash flow from financing activities is currently $87.00 million, with the most recent change of -$32.70 million (-27.32%) on 31 December 2023. CGON annual CFF is now -27.32% below its all-time high of $119.69 million, reached on 31 December 2022.CGON Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$2.17 M
+$2.13 M+5317.50%
30 September 2024
Summary:
CG Oncology Common stock quarterly cash flow from financing activities is currently $2.17 million, with the most recent change of +$2.13 million (+5317.50%) on 30 September 2024. Over the past year, it has dropped by -$103.72 million (-97.95%). CGON quarterly CFF is now -99.46% below its all-time high of $402.66 million, reached on 31 March 2024.CGON Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$401.97 M
-$103.72 M-20.51%
30 September 2024
Summary:
CG Oncology Common stock TTM cash flow from financing activities is currently $401.97 million, with the most recent change of -$103.72 million (-20.51%) on 30 September 2024. Over the past year, it has increased by +$312.08 million (+347.16%). CGON TTM CFF is now -20.51% below its all-time high of $505.69 million, reached on 30 June 2024.CGON TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGON Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.3% | -98.0% | +347.2% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CGON Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -27.3% | +463.2% | -99.5% | +114.2% | -20.5% | +2613.9% |
| 5 y | 5 years | -27.3% | +463.2% | -99.5% | +114.2% | -20.5% | +2613.9% |
| alltime | all time | -27.3% | +463.2% | -99.5% | +114.2% | -20.5% | +2613.9% |
CG Oncology Common Stock Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.17 M(+5317.5%) | $401.97 M(-20.5%) |
| June 2024 | - | $40.00 K(-100.0%) | $505.69 M(+3.1%) |
| Mar 2024 | - | $402.66 M(<-9900.0%) | $490.42 M(+463.7%) |
| Dec 2023 | $87.00 M | -$2.90 M(-102.7%) | $87.00 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $105.88 M(-795.5%) | $89.89 M(-662.2%) |
| June 2023 | - | -$15.22 M(+1890.2%) | -$15.99 M(+1990.2%) |
| Mar 2023 | - | -$765.00 K | -$765.00 K |
| Dec 2022 | $119.69 M(+674.9%) | - | - |
| Dec 2021 | $15.45 M | - | - |
FAQ
- What is CG Oncology Common stock annual cash flow from financing activities?
- What is the all time high annual CFF for CG Oncology Common stock?
- What is CG Oncology Common stock annual CFF year-on-year change?
- What is CG Oncology Common stock quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for CG Oncology Common stock?
- What is CG Oncology Common stock quarterly CFF year-on-year change?
- What is CG Oncology Common stock TTM cash flow from financing activities?
- What is the all time high TTM CFF for CG Oncology Common stock?
- What is CG Oncology Common stock TTM CFF year-on-year change?
What is CG Oncology Common stock annual cash flow from financing activities?
The current annual CFF of CGON is $87.00 M
What is the all time high annual CFF for CG Oncology Common stock?
CG Oncology Common stock all-time high annual cash flow from financing activities is $119.69 M
What is CG Oncology Common stock annual CFF year-on-year change?
Over the past year, CGON annual cash flow from financing activities has changed by -$32.70 M (-27.32%)
What is CG Oncology Common stock quarterly cash flow from financing activities?
The current quarterly CFF of CGON is $2.17 M
What is the all time high quarterly CFF for CG Oncology Common stock?
CG Oncology Common stock all-time high quarterly cash flow from financing activities is $402.66 M
What is CG Oncology Common stock quarterly CFF year-on-year change?
Over the past year, CGON quarterly cash flow from financing activities has changed by -$103.72 M (-97.95%)
What is CG Oncology Common stock TTM cash flow from financing activities?
The current TTM CFF of CGON is $401.97 M
What is the all time high TTM CFF for CG Oncology Common stock?
CG Oncology Common stock all-time high TTM cash flow from financing activities is $505.69 M
What is CG Oncology Common stock TTM CFF year-on-year change?
Over the past year, CGON TTM cash flow from financing activities has changed by +$312.08 M (+347.16%)